Low-intensity PSMA uptake is reported in breast carcinoma, lymphoma, meningioma, squamous cell carcinoma, and well-differentiated thyroid carcinoma (particularly iodine refractory types) [76,77,78]. Here, FOLH1 is linked to meningioma.